The short version: Salvia divinorum is the most potent naturally occurring psychedelic, but it works through kappa opioid receptors, not the serotonin system like psilocybin or LSD. High doses can produce an intense, dissociation-like state. Its abuse potential appears low. It is not a treatment; this is a research and educational overview, not clinical or safety advice.
Someone once described a high-dose Salvia experience to me as feeling like they had left their own body. The clinical word for that is “dissociation,” and it turns out that word carries more baggage than the experience itself.
That gap, between what people actually experience with Salvia divinorum and the language we reach for to describe it, is one of my favorite things to talk about. I got to do exactly that with Nick Jikomes on his Mind & Matter podcast. We covered traditional Mazatec ceremonies, how Salvia’s effects differ from other psychedelics, and my research years at the Institute of Transpersonal Psychology and Yale School of Medicine. Nick took a deep dive through some of my research papers to talk about interoception, dysphoria, and the phenomenon of dissociation. We also talked about activism, the problems with profit-driven healthcare, and my love of Allen Ginsberg’s poetry. (I said Howl was published in the early 60s and I was wrong. It was written in 1954 and 1955, it is amazing, and you should listen to it right now.)
This post pulls together what I keep coming back to across that conversation and other talks I’ve given on Salvia: how it works, what it does, and why it deserves more clinical curiosity than it usually gets.
Indigenous Use and Cultural Context
The Mazatec people of southern Mexico work with many plants and fungi as tools to treat illness and to reach spiritual dimensions. Their healing toolbox includes psilocybin-containing mushrooms and Salvia divinorum, among others.
The Mazatec believe that proper singing and preparation of mind and body during a ritual may facilitate the healing effects of Salvia. That belief, and the tradition it belongs to, preserved this plant and its knowledge long before any research lab looked at it. Any honest discussion of Salvia’s clinical potential starts by acknowledging that.
How Salvia Works
The active component of Salvia is salvinorin A (SA), the most potent naturally occurring psychedelic by weight and a highly selective kappa opioid receptor agonist (Roth et al., 2002, PNAS). This is what makes it genuinely different from the classic psychedelics. Psilocybin and LSD work primarily on the serotonin 2A receptor. Salvinorin A does not touch that system at all. It acts on the kappa opioid system, which is why its effects feel so unlike a “typical” psychedelic to people who have tried both.
Unlike many drugs of abuse, salvinorin A does not appear to alter dopamine levels in the brain’s reward pathway, which is consistent with low abuse potential in both animal and human research (Butelman & Kreek, 2015, Frontiers in Pharmacology). It produces a trance-like effect without the reinforcing, habit-forming signature of addictive substances. Some peripheral anti-inflammatory effects have also been reported in animal models, where salvinorin A reduced inflammatory markers through both kappa opioid and CB1 receptors (Aviello et al., 2011, Journal of Molecular Medicine). That last finding is early and preclinical, and worth watching rather than overselling.
Salvia and Dissociation
High doses of Salvia can produce an intense, dissociation-like state: a sense of disconnection from external reality, reduced control over thoughts and body, and difficulty interacting with one’s surroundings. Lower doses are different, and can instead heighten trust in bodily sensations.
Here’s where the language matters. “Dissociation” in a psychiatric sense usually refers to a trauma-related experience of detachment that is distressing and unwanted. The disconnection people describe on Salvia shares surface features with that, but it is pharmacologically driven, time-limited, and phenomenologically its own thing. Collapsing the two under one word is easy and slightly misleading, which is exactly why it’s worth pulling apart.
Dissociation as a broader phenomenon does show up often in therapy. Meditation, breath exercises, yoga, and other movement practices can help someone move back toward their body and out of a dissociated state. As I told Nick, paying attention beats not paying attention, and focusing on breath and body movement is a concrete way to do that.
Therapeutic Potential, Honestly Assessed
Because salvinorin A works on the kappa opioid system, it has drawn research interest for conditions where that system is implicated, including mood, substance use, and pain. I’ve made the case in other talks that this deserves clinical curiosity rather than dismissal, not because Salvia is a proven treatment, but because writing it off entirely throws away real and unusual pharmacology.
Two caveats hold that curiosity in check. First, most of the therapeutic-potential evidence is animal and primate research, not human clinical trials. Second, kappa opioid agonism tends to produce dysphoria, the opposite of a pleasant “high,” which complicates any straightforward therapeutic use. The interesting scientific questions and the honest clinical answer (“we don’t have the human evidence yet”) both matter, and neither cancels the other out.
If you want the fuller picture from my other conversations on this plant, I go deeper into the research in my 2017 MAPS conference talk on Salvia’s therapeutic potential and into consciousness and embodiment in my 2019 Psychedelics Today conversation.
Take Care of Yourself
That Mind & Matter conversation was recorded in January 2021, and it ended with my advice for staying healthy during the pandemic. It still holds: nourish your relationships with yourself, other people, and the natural world. Whatever you make of the pharmacology, that part isn’t complicated.
Frequently Asked Questions
What is salvinorin A?
Salvinorin A is the active compound in Salvia divinorum and the most potent naturally occurring psychedelic by weight. Unlike psilocybin or LSD, it works on the kappa opioid receptor rather than the serotonin system, which is why its effects are so distinct from other psychedelics.
Is Salvia divinorum’s dissociation the same as clinical dissociation?
Not exactly. The two share surface features (a sense of detachment from the body or surroundings), but Salvia’s version is pharmacologically driven and time-limited, while clinical or trauma-related dissociation is a distressing, often chronic psychiatric experience. Using one word for both is convenient but blurs a real difference.
Is Salvia divinorum addictive?
Current research suggests low abuse potential. Salvinorin A does not appear to raise dopamine in the brain’s reward pathway, and kappa opioid agonists like it are not typically self-administered in animal models. It also tends to produce dysphoria rather than euphoria, which further limits its reinforcing quality.
Is Salvia divinorum a treatment for any condition?
No. There is real research interest in the kappa opioid system for mood, substance use, and pain, but the therapeutic-potential evidence for salvinorin A is largely preclinical (animal and primate studies). It is not an approved or established treatment for any condition, and this overview is educational, not clinical advice.
Curious about working together? Get in touch.
Peter H. Addy, PhD, LPC, LMHC is a Portland-based licensed psychotherapist specializing in psychedelic-informed and harm-reduction psychotherapy, ketamine-assisted psychotherapy, and chronic pain. His research background includes postdoctoral work at Yale School of Medicine on psychedelic substances. Learn more about my practice →
